Review articles
Last updated August 14, 2023
13. Aksnes H, McTiernan N, Arnesen T (2023). NATs at a glance. J Cell Sci 136 (14): jcs260766.
12. Aksnes H, Ree R, Arnesen T (2019). Co-translational, Post-translational, and Non-catalytic Roles of N-Terminal Acetyltransferases. Mol Cell 73(6):1097-1114.
11. Ree R, Varland S, Arnesen T (2018). Spotlight on protein N-terminal acetylation. Exp Mol Med 50(7):90.
10. Aksnes H, Drazic A, Marie M, Arnesen T (2016). First Things First: Vital Protein Marks by N-Terminal Acetyltransferases. Trends Biochem Sci 41(9):746-60.
9. Drazic A, Myklebust LM, Ree R, Arnesen T (2016). The world of protein acetylation. Biochim Biophys Acta 1864(10):1372-401.
8. Varland S, Osberg C, Arnesen T (2015). N-terminal modifications of cellular proteins: the enzymes involved, their substrate specificities and biological effects. Proteomics15(14):2385-401.
7. Kalvik TV and Arnesen T (2013). Protein N-terminal acetyltransferases in cancer. Oncogene 32(3):269-76.
6. Starheim KK, Gevaert K, Arnesen T (2012). Protein N-terminal acetyltransferases: when the start matters. Trends Biochem Sci 37(4):152-61.
5. Van Damme P, Arnesen T, Gevaert K (2011). Protein alpha-N-acetylation studied by N-terminomics. FEBS J 278(20):3822-34.
4. Arnesen T. (2011) Towards a functional understanding of protein N-terminal acetylation. PLoS Biology 9(5): e1001074.
3. Starheim KK, Gromyko D, Velde R, Varhaug JE, Arnesen T. (2009) Composition and biological significance of the human Nα-terminal acetyltransferases. BMC Proc. 3 (Suppl 6):S3
2. Polevoda B, Arnesen T, Sherman F. (2009) A synopsis of eukaryotic Nα-terminal acetyltransferases: nomenclature, subunits and substrates. BMC Proc. 3 (Suppl 6):S2.
1. Arnesen T, Thompson PR, Varhaug JE, Lillehaug JR. (2008) The protein acetyltransferase ARD1 – a novel cancer drug target? Curr Cancer Drug Targets. 8:545-553.